To test the effect of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) on doxorubicin (DOX)-induced cardiotoxicity. Methods: We used neonate rat cardiomyocytes and an acute mouse model of DOX-induced cardiotoxicity to examine the protective effect of THSG. Results: In the mouse model, administration of THSG signifi cantly reduced DOX-induced cardiotoxicity, including animal mortality, histopathological changes, and levels of serum creatine kinase (CK) and lactate dehydrogenase (LDH). Moreover, THSG was able to attenuate the increased malondialdehyde (MDA) and decreased reduced glutathione (GSH) caused by DOX. In in vitro studies, THSG 10−300 μmol/L ameliorated DOX-induced cardiomyocyte apoptosis in a concentration-dependent manner. Further studies showed that THSG inhibited reactive oxygen species (ROS) generation and prevented DOX-induced loss of mitochondrial membrane potential, caspase-3 activation and upregulation of Bax protein expression. We observed a protective response against damage after DOX treatment. The level of Bcl-2 protein was increased. Additionally, THSG inhibited a DOX-induced [Ca 2+ ] increase. Conclusion: These results showed that THSG protected against DOX-induced cardiotoxicity by decreasing ROS generation and intracellular [Ca 2+ ] and by inhibiting apoptotic signaling pathways.
Introduction
Doxorubicin (also called adriamycin) is an anthracycline antibiotic that has been used for more than 30 years for the treatment of a wide variety of cancers. However, severe cardiomyopathy and heart failure have been observed in DOXtreated cancer patients [1] , which limits clinical chemotherapy. It is widely accepted that oxidative stress and the production of free radicals are involved in DOX-induced cardiotoxicity [2] [3] [4] [5] [6] [7] . The quinone moiety of DOX is prone to the generation of oxygen radicals through an enzymatic mechanism utilizing mitochondrial respiratory chain and non-enzymatic pathways that incorporate iron [8, 9] . DOX-induced cardiomyocyte apoptosis has been further reported in specifi c conditions [10, 11] , and mitochondrial dysfunction has a signifi cant role in contributing to DOX-induced apoptosis [12] [13] [14] . Polygonum multifl orum Thunb, a traditional Chinese medicinal herb, has been used for thousands of years as a tonic and anti-aging agent. THSG is one of the active components extracted from Polygonum multiflorum Thunb and has been shown to exhibit strong antioxidant activity in vitro [15] . Researchers have shown that THSG can diminish peroxidation levels in the brain in a mouse model of Alzheimer's disease [16] or cerebral ischemia-reperfusion [17] . Structurally, THSG belongs to the hydroxystilbene group (Figure 1) , and its structure is similar to that of resveratrol extracted from red wine, which has significant protective effects on cardiomyocyte injury. Based on these previous reports, we envisioned that THSG might protect the heart from DOX-induced injury.
In the present study we used neonatal rat cardiomyocytes in vitro and an acute mouse model of DOX-induced cardiotoxicity to examine the protective effects of THSG as well as the underlying mechanisms. [18] . Anti-caspase-3, anti-Bax, anti-Bcl-2, and antiactin were purchased from Santa Cruz Biotechnology. The Super Signal West Pico chemiluminescence substrate was obtained from PIERCE Biotechnology. The TUNEL assay kit was obtained from Wuhan Boster Biological Technology. Methylthiazolyldiphenyl-tetrazo lium bromide (MTT), 5,5',6,6'-tetrachloro-1,1',3,3'-tetra ethyl benzi mida zolo carbocyanine iodide (JC-1), and 2',7'-dichloro dihydro fluo rescein diacetate (DCFH-DA) were obtained from the Beyotime Institute of Biotechnology. Fluo 3-AM was purchased from SigmaAldrich. MDA, GSH, LDH, and CK assay kits were purchased from the Nanjing Jiancheng Bioengineering Institute.
Materials and methods

Drugs and chemicals
Animals and treatments
Kunming male mice of inbred strain, 20-24 g body weight, were randomly divided into three groups consisting of 20 animals each. The animals were housed under standard conditions and were given free access to food and tap water. DOX was intraperitoneally (ip) injected at a dose of 15 mg/kg, which is well-documented to induce cardiotoxicity in mice. THSG was administered at a dose of 0.1 g·kg
, which was selected on the basis of previous studies [19] . The DOX group received a single dose of DOX following treatment with isotonic saline for five days. The group that was administered with THSG was treated for two days prior to a single dose of DOX and for fi ve days after. The control group received a single dose via ip injection of isotonic saline following treatment with isotonic saline for five days. All animal care and experimental protocols complied with the Animal Management Rules of the Health Ministry of the People's Republic of China (document No 55, 2001 ).
Sample collection and biochemical assays
At the end of the treatment, all animals were decapitated, and blood samples were collected. The plasma was removed immediately for the LDH and CK assay. The heart was quickly isolated, blotted dry on filter paper, and weighed. Thereafter, a 10% homogenate of the heart was made in icecold saline to determine MDA and GSH concentrations. The reagent kits were used to determine the biochemical indicators.
Histopathological examinations
The tissues were fixed in 10% formalin, routinely processed and embedded in paraffi n. Sections were cut at 5-μm thicknesses and stained with hematoxylin and eosin. The sections were then viewed under a light microscope for histopathological changes.
Isolation and cultivation of rat cardiomyocytes Primary cultures of cardiomyocytes from neonatal (2-4 days old) Wistar rats were prepared according to the published method [20] . The cell suspension was adjusted to a density of 3×10 5 -5×10 5 cells/mL and seeded in 6-or 96-well plastic plates. Forty-eight hours after seeding, the attached cells began to contract spontaneously. The experiments were performed between three and four days after cultivation.
Cell viability assay
The cell viability was measured using the MTT assay, which is based on the conversion of MTT to formazan crystals by mitochondrial dehydrogenase. For our purpose, cells were seeded in 96-well plates and then received 1 μmol/L DOX either alone or with THSG (3~300 μmol/L) pretreatment 2 h before. After incubation for up to 24 h, MTT solution (5 mg/mL in D-Hanks' solution) was added to the 96-well plates, and the cells were allowed to incubate for 4 h at 37 °C. After the medium was removed and regular medium was added to prevent the drugs from reacting directly with MTT, the cells and formazan were dissolved by adding dimethylsulfoxide (DMSO), and the light absorbance was measured at 490 nm in a microtiter plate reader.
Cardiomyocyte apoptosis
Cardiomyocyte apoptosis was evaluated via the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method according to the manufacturer's instructions. Labeled DNA was visualized with peroxidaseconjugated anti-digoxigenin antibody with 3,3'-diaminobenzidene as the chromagen. The quantification of apoptosis was determined by counting TUNEL-positive cardiomyocyte nuclei from ten random fi elds per section and was expressed as a percentage of total nuclei.
Determination of ROS generation
To measure intracellular ROS formation, the fl uorescent probe DCFH-DA was used. Briefly, the cardiomyocytes attached to plates were loaded with 10 μmol/L DCFH-DA in serumfree medium at 37 °C for 20 min, and the plates were washed three times with serum-free medium and used for the treatment with various drugs. Fluorescence of ROS in cardiomyocytes was recorded with a confocal scanning laser microscope (FV500, Olympus, Japan) and analyzed with PathVision imaging software.
Measurement of mitochondrial membrane potential
The mitochondrial membrane potential was studied using the probe JC-1, which exists either as a green fl uorescent monomer 
Western blot analysis
After the treatment, the cells were washed twice with cold PBS and solubilized in lysis buffer. Fifty micrograms of protein sample were separated by 12% SDS-polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. The membrane was incubated with anti-caspase 3, anti-Bax, anti-Bcl-2 and anti-actin as primary antibodies in 5% nonfat milk in PBS with 0.1% Tween 20, followed by incubation with horseradish peroxidase-conjugated IgG as the secondary antibody. The chemiluminescence reaction was carried out using an ECL kit. ] i signal in cardiomyocytes was measured for 5 min with a confocal scanning laser microscope.
Statistical analysis
Data were expressed as mean±SD based on the data derived from multiple independent experiments. Statistical differences were determined by ANOVA followed by a Student's t-test. P values below 0.05 were considered statistically signifi cant.
Results
Effects of DOX and THSG treatment on animal body weight and survival DOX treatment for five days reduced the animals' body weights compared with the control (21.8±3.6 g vs 25.6±2.6 g, P<0.01). Treatment with THSG did not increase the animal's body weight (22.5±2.8 g, P>0.05, compared with DOX alone). There was no difference in the heart weight/body weight ratio among the three groups (4.5±0.6 mg/g in control group, 4.3±0.7 mg/g in DOX treatment and 4.3±0.4 mg/g in THSG treatment). At the end of the treatment period, all animals in the control group were alive. However, only 70% of the animals in the DOX-alone group survived. THSG-treated animals had a compromised survival rate of 85% compared with DOX alone (log rank test, P>0.05).
Effects of DOX and THSG treatment on serum LDH and CK and heart MDA and GSH The activities of serum LDH and CK have been widely used clinically as parameters for the diagnosis of cardiac diseases. As shown in Table 1 , DOX alone induced signifi cant increases in serum LDH and CK levels compared with the control, and these increases were effectively attenuated by THSG treatment. DOX treatment also led to a significant increase in MDA and a depletion in GSH compared with that of the control group. The combination of THSG and DOX provided marked normalization in MDA and GSH concentrations compared with the DOX-alone group.
THSG attenuated DOX-induced heart histological changes Normal heart histological findings were seen in the control group (Figure 2A) . However, there were histological changes in the DOX group ( Figure 2B-2C) , including the presence of marked interstitial edema, focal subendocardial hemorrhage, and destruction or loss of cardiac muscle fi bers, all of which was qualitatively recognized as DOX-induced cardiac damage. The lesions were significantly reduced in the group treated with THSG compared with the DOX group ( Figure 2D) . THSG increased the viability of DOX-treated cells The effect of THSG on the cytotoxicity of DOX was detected by the MTT assay. As shown in Figure 3 , after treatment with 300 μmol/L THSG for 24 h, no obvious effect was seen, as the cell viability was 102.5%±5.9% (P>0.05, compared with the control). DOX alone markedly affected cell survival, as the rate of cell survival after exposure to 1 μmol/L DOX for 24 h was about 72%. In the presence of THSG, cell viability was signifi cantly enhanced in a concentration-dependent manner. With the exception of the 3 μmol/L THSG group, all THSG groups had significant differences compared with the DOXalone group, indicating that THSG inhibited DOX-induced cell death.
THSG inhibited DOX-induced apoptosis
Compared with the control cells, more apoptotic nuclei were identified in the cells grown in medium with DOX ( Figure  4A−4B) , and the rate of positive cells was 34.2%±4.5% by quantitative analysis. As shown in Figure 4C ,D, E, treatment with 10−300 μmol/L THSG decreased the number of apoptotic nuclei after DOX incubation in a concentration-dependent npg manner, and all groups had signifi cant differences compared with the DOX-alone group, which was consistent with the results obtained from the MTT assay. These results confi rmed that apoptosis of cardiomyocytes could be induced by DOX and that THSG could attenuate DOX-induced apoptosis.
THSG prevented DOX-induced loss of mitochondrial membrane potential Nearly all cells were well-spread and exhibited red or orange fluorescence in untreated culture ( Figure 5A ). By contrast, treatment with DOX for 24 h ( Figure 5B ) demonstrated multiple rounded cells, a majority of which fl uoresced green exclusively, indicating loss of mitochondrial membrane potential. The cells pretreated with THSG appeared similar to the control cells, with spread cells exhibiting red or orange fl uorescence ( Figure 5C ). Ratios of JC-1 aggregates/monomeric forms in all groups ( Figure 5D ) indicate that DOX-induced loss of the mitochondrial membrane potential was prevented by THSG.
THSG inhibited DOX-induced ROS generation
Treatment with 300 μmol/L THSG for 24 h had no effect on ROS levels in untreated cells ( Figure 6A-6B ). As shown in Figure 6C , treatment of cells with DOX stimulated a signifi cant increase in the ROS level. The increase in ROS production was signifi cantly reduced by pretreatment with 300 μmol/L THSG for 2 h ( Figure 6D) . A direct comparison of ROS levels in all groups is summarized in Figure 6E . These results indicate that THSG attenuates DOX-induced intracellular ROS accumulation. Effects of THSG and DOX on the expression of apoptosis-related proteins To examine the molecular mechanism of THSG against DOXinduced apoptosis, the effects of THSG on DOX-mediated caspase-3 activation and the changes in the protein levels of Bax and Bcl-2 were determined by Western blot assay. As shown in Figure 7 , treatment of the cells with 1 μmol/L DOX for 24 h induced the cleavage of procaspase-3 (32 kDa) to its 17-kDa subunits. However, cleavage of procaspase-3 to its subunits was inhibited by THSG in a dose-dependent manner. Preincubation with 300 μmol/L THSG for 2 h completely eliminated caspase-3 activation in DOX-treated cells, indicating that DOX activates caspase-3, and this step is prevented by THSG. Bcl-2 family proteins have an important role in regulating cytochrome c release and caspase-3 activation. Bcl-2, an antiapoptotic protein, prevents the release of cytochrome c from mitochondria, whereas Bax, a pro-apoptotic protein, promotes release of cytochrome c from mitochondria. As shown in Figure 7 , treatment of cells with DOX induced a marked increase in the protein level of Bcl-2. Pre-incubation with THSG made this potentially adaptive response more outstanding. Compared with the control, the abundance of Bax was increased after the addition of DOX, indicating that Bax is involved in the apoptotic signaling induced by DOX treatment. After pretreatment with THSG, Bax protein induction was reduced in a dose-dependent manner ( Figure 7B ). These results suggest that THSG might attenuate the apoptotic effects of DOX partly by inhibiting caspase-3 activation, Bax induction and improving Bcl-2 protein expression. npg Discussion DOX-induced cardiotoxicity manifests itself in acute, subacute and chronic forms [21] . In the current studies of DOX cardiotoxicity, the single high-dose model and the low-dose chronic model are both widely used, which provides valuable biological insights into DOX-induced cardiac injury. For the single high-dose model, the dosage is equivalent to a high-dose single injection in cancer patients [22] . In the current study, we applied the single high-dose model and investigated whether THSG protects the heart from acute DOX toxicity. The results showed that THSG greatly decreased the DOX-associated elevation of serum LDH and CK activities, two nonspecifi c but widely used cardiac injury markers. Furthermore, THSG attenuated DOX-induced animal mortality and histology changes. These fi ndings indicate that THSG is a potential protective agent against DOX injury. It is known that enhanced oxidative stress and antioxidant defi cit play significant parts in DOX-induced cardiomyopathy and congestive heart failure [23] . The fi ndings of the present study conform to this understanding, as elevated cardiac lipid peroxidation, accompanied by deteriorating antioxidant status, was evident in the DOX group. However, THSG administration prevented an upsurge in oxidative stress, as shown by the low level of tissue lipid peroxides in the treated group. The restoration of the normal levels of GSH antioxidant molecules in the THSGtreated group highlight the protection rendered by THSG in combating the oxidative insult. This fi nding indicates that the protective effect of THSG involves its antioxidant activity and radical scavenging.
Another important mechanism of DOX-induced cardiotoxicity is apoptosis. In regard to the mitochondrial pathway, several studies have shown that DOX induces apoptosis by favoring cytochrome c release and the consequent formation of the apoptotic complex through up-regulation of Bax [10, 24] or down-regulation of Bcl-2 [25, 26] . The results obtained from this study confirmed that apoptosis of cardiomyocytes could be induced by DOX because DOX induced caspase-3 activation and increased Bax expression. THSG was able to inhibit DOXinduced apoptosis in the cardiomyocytes. This inhibition correlated with the inhibitory effect of THSG on DOX-induced caspase-3 activation and increased Bax protein expression. Of note, we observed that DOX induced a marked increase in the protein level of Bcl-2, and THSG treatment promoted this adaptive response. Perhaps this increase is involved in some protective responses that occur against subsequent damage after DOX treatment.
DOX was able to enhance the formation of ROS in heart tissue. Excessive production of ROS may induce cell damage via apoptosis in any cell type, and such effects can be blocked by a wide variety of antioxidants [27, 28] . In line with this notion, we observed that DOX-induced intracellular ROS accumulation was attenuated by THSG, as revealed by reduced distribution of the DCFH-DA fl uorescent dye in cells pretreated with THSG. Many reports have demonstrated that cytochrome c-dependent caspase-3 activation is an important mechanism responsible for ROS-induced apoptosis in vivo and in vitro [29] . We found that DOX activated caspase-3, and this activation could be prevented by THSG, indicating that THSG reduced DOX-induced apoptosis through the inhibition of caspase-3 activation, which is, at least in part, induced by ROS.
Apoptotic responses may refl ect direct opening of the mitochondrial permeability transition by O 2 · and H 2 O 2 formed during the redox cycling of DOX [14, 30] . Accumulation of the more lipophilic 7-deoxyaglycone of DOX in the inner mitochondrial membrane greatly enhances electron deviation from the regular respiratory chain pathway to oxygen, leading to an increased formation of O 2 · and H 2 O 2 and consequent amplification of mitochondrial dysfunction [31] . In the current study, where cardiomyocytes were exposed to DOX, rapid depolarization of the mitochondrial membrane potential was also observed, which is indicative of mitochondrial dysfunction; this dysfunction was alleviated by pretreatment with THSG. Taken together, the present study demonstrates that THSG suppresses DOX-induced cardiomyocyte apoptosis through inhibition of the mitochondrial cytochrome c release-mediated apoptotic pathway, which is triggered by the increased levels of ROS generated by DOX.
Although the theory has received less attention than ROS, homeostasis is one possible mechanism of cardiotoxicity. DOX increases the probability of sarcoplasmic reticulum (SR) calcium release channels being open [32, 33] , thereby inhibiting the Na + -Ca 2+ exchanger [34] or activating L-type cardiac calcium channels [35] . In addition, an increase in the concentration of intracellular Ca 2+ initiates a critical step for apoptosis by promoting ROS generation [36] and modulating a transition in mitochondrial permeability by opening permeability transition pores, thereby releasing cytochrome c [37, 38] . Moreover, there is a close link between DOXinduced ROS generation and an increase in [Ca 2+ ] i , and a DOXinduced [Ca 2+ ] i increase is inhibited by pretreatment with antioxidants [39] . Consistent with these observations, our studies demonstrate that DOX-mediated increases in [Ca 2+ ] i are reduced by treatment with THSG, which also inhibits DOXinduced ROS generation.
We also found that THSG itself might have therapeutic potential as a protective agent. A previous report has proven that THSG inhibits tumor growth and lung metastasis [40] . We also found that 1-100 μmol/L of THSG inhibited MCF-7 cell proliferation by conspicuously depressing the PI3K/Akt sig- In summary, THSG appears to be a promising drug to be used in combination with DOX to ameliorate the cardiotoxicity while increasing the clinical efficacy of DOX and improving patients' quality of life.
